Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 28, 2017

Primary Completion Date

July 1, 2020

Study Completion Date

September 4, 2020

Conditions

Type1 Diabetes Mellitus

Interventions

DRUG

ProTrans: Allogeneic transplantation with WJMSCs

The drug is a cell suspension with allogeneic mesenchymal stromal cells derived from umbilical cord tissue.

DRUG

Placebos

Placebo treatment

Trial Locations (1)

Karolinska Trial Alliance, Fas 1 enheten, Karolinska Universitetssjukhuset Huddinge, Stockholm